Bisphosphonates and mortality: confounding in observational studies?

Association of Alendronate and Risk of Cardiovascular Events in Patients With Hip Fracture

(2018) Chor-Wing Sing et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Fracture Prevention with Zoledronate in Older Women with Osteopenia

(2018) Ian R. Reid et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Swedish cause of death register

(2017) Hannah Louise Brooke et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Bisphosphonates for cardiovascular risk reduction: A systematic review and meta-analysis

(2016) Guido Kranenburg et al.   ATHEROSCLEROSIS

Oral Bisphosphonates and Improved Survival of Breast Cancer

(2016) Gad Rennert et al.   CLINICAL CANCER RESEARCH

Preadmission Bisphosphonate and Mortality in Critically Ill Patients

(2016) Paul Lee et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study

(2015) W. Brozek et al.   OSTEOPOROSIS INTERNATIONAL

Bisphosphonate Therapy, Death, and Cardiovascular Events Among Female Patients With CKD: A Retrospective Cohort Study

(2012) James E. Hartle et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments

(2012) Charles A. Inderjeeth et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients—a nationwide register-based open cohort study

(2012) L. Bondo et al.   OSTEOPOROSIS INTERNATIONAL

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate—Danish National Register Based Cohort Study

(2012) M. Pazianas et al.   OSTEOPOROSIS INTERNATIONAL

Propensity score applied to survival data analysis through proportional hazards models: a Monte Carlo study

(2012) Etienne Gayat et al.   PHARMACEUTICAL STATISTICS

External review and validation of the Swedish national inpatient register

(2011) Jonas F Ludvigsson et al.   BMC PUBLIC HEALTH

Bisphosphonates: The first 40years

(2011) R. Graham G. Russell   BONE

Osteoporosis Medication and Reduced Mortality Risk in Elderly Women and Men

(2011) Jacqueline R. Center et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

(2011) Peter C. Austin   MULTIVARIATE BEHAVIORAL RESEARCH

Outcome of Patients With Early Breast Cancer Receiving Nitrogen-Containing Bisphosphonates: A Comparative Analysis From the Metropolitan Detroit Cancer Surveillance System

(2010) Zeina Nahleh et al.   Clinical Breast Cancer

Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis

(2010) Mark J. Bolland et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Oral bisphosphonates are associated with reduced mortality after hip fracture

(2010) L. A. Beaupre et al.   OSTEOPOROSIS INTERNATIONAL

Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study

(2010) P. N. Sambrook et al.   OSTEOPOROSIS INTERNATIONAL

Development and use of FRAX® in osteoporosis

(2010) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Post-Fracture Prescribed Calcium and Vitamin D Supplements Alone or, in Females, with Concomitant Anti-Osteoporotic Drugs is Associated with Lower Mortality in Elderly Hip Fracture Patients

(2009) Ilona Nurmi-Lüthje et al.   DRUGS & AGING

Hip Fracture Causes Excess Mortality Due to Cardiovascular and Infectious Disease in Institutionalized Older People: A Prospective Five-Year Study

(2009) Ian D Cameron et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Potential mediators of the mortality reduction with zoledronic acid after hip fracture

(2009) Cathleen S Colón-Emeric et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The completeness of the Swedish Cancer Register – a sample survey for year 1998

(2008) Lotti Barlow et al.   ACTA ONCOLOGICA